York Pharma Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
23
- Latest Deal Type
-
Liquidation
York Pharma General Information
Description
Distributor of prescription products based in Milton Keynes, United Kingdom. The company is engaged in developing, marketing and supplying prescription products to pharmaceutical wholesalers, hospitals and general practitioners in the dermatology field.
Contact Information
Website
www.yorkpharma.comCorporate Office
- YORK House
- 327 Upper Fourth Street
- Milton Keynes MK9 1EH
- England, United Kingdom
Corporate Office
- YORK House
- 327 Upper Fourth Street
- Milton Keynes MK9 1EH
- England, United Kingdom
York Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Bankruptcy: Liquidation | 27-Jul-2009 | Completed | Out of Business | |||
| 7. Debt - General | 07-Apr-2009 | Completed | Profitable | |||
| 6. PIPE | 01-Oct-2008 | Completed | Profitable | |||
| 5. Grant | 14-Jun-2006 | Completed | Generating Revenue | |||
| 4. Grant | 22-Mar-2005 | Completed | Generating Revenue | |||
| 3. PIPE | 01-Feb-2005 | Completed | Generating Revenue | |||
| 2. PIPE | 01-Dec-2004 | $5.23M | $5.23M | Completed | Generating Revenue | |
| 1. IPO | 06-May-2004 | Completed | Generating Revenue |
York Pharma Patents
York Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-0814009-D0 | Novel process, products and intermediadiates | Inactive | 31-Jul-2008 | ||
| GB-0720716-D0 | Novel formulation | Inactive | 23-Oct-2007 | ||
| GB-0715141-D0 | Improving skin barrier function | Inactive | 03-Aug-2007 | ||
| GB-0617191-D0 | Improvements in pharmaceutical compositions | Inactive | 31-Aug-2006 | ||
| GB-0604899-D0 | Derivatives of 18-glycyrrhetinic acid | Inactive | 10-Mar-2006 | C07J63/008 |
York Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
York Pharma Investments & Acquisitions (6)
York Pharma’s most recent deal was a Merger/Acquisition with Patient Plus for . The deal was made on 02-Mar-2011.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Patient Plus | 02-Mar-2011 | Merger/Acquisition | Distributors (Healthcare) | ||
| CellTran | 28-Oct-2008 | Merger/Acquisition | Drug Discovery | ||
| Flammazine and Flammacerium | 03-Jul-2008 | Corporate Asset Purchase | Buildings and Property | ||
| DermsDevelopments | 09-Oct-2007 | Merger/Acquisition | Personal Products | ||
| Rosanto Pharmaceuticals | 24-Apr-2007 | Merger/Acquisition | Drug Discovery |
York Pharma Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| DermsDevelopments | Knutsford, United Kingdom | 2006 | |
| Molecular Skincare | Sheffield, United Kingdom | 2001 |
York Pharma FAQs
-
When was York Pharma founded?
York Pharma was founded in 2002.
-
Where is York Pharma headquartered?
York Pharma is headquartered in Milton Keynes, United Kingdom.
-
What is the size of York Pharma?
York Pharma has 23 total employees.
-
What industry is York Pharma in?
York Pharma’s primary industry is Distributors (Healthcare).
-
Is York Pharma a private or public company?
York Pharma is a Private company.
-
What is York Pharma’s current revenue?
The current revenue for York Pharma is .
-
How much funding has York Pharma raised over time?
York Pharma has raised $32.4M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
